Ares Management (ARES) Misses Q1 Earnings and Revenue Estimates

Ares Management reported Q1 2026 adjusted EPS of $1.24, missing the $1.32 consensus by 6.2%, while revenue of $1.29 billion also fell short of estimates by 2.5%. EPS rose from $1.09 a year ago, but the company has beaten consensus EPS only once in the last four quarters, and shares are down 27.4% year to date. The stock’s near-term direction will depend on management commentary and whether estimate revisions improve after the report.

Analysis

The miss matters less as a single quarter than as a signal that ARES is losing the market’s most valuable asset: credibility on forward fee and realization assumptions. In private markets, a pattern of under-delivery on both revenue and EPS usually forces analysts to de-rate the near-term multiple before the business fundamentals fully roll over, because the market price is anchored to distributable earnings stability, not GAAP growth. The stock’s drawdown year-to-date suggests investors are already discounting slower fee-related earnings momentum, but repeated estimate misses increase the odds of another leg down if management cannot re-accelerate fundraising, deployment, or exits.

The second-order risk is competitive, not just company-specific. If ARES is showing softer conversion from AUM growth into earnings, that can reflect weaker monetization across the broader private credit / alternatives complex: competitors with more sticky perpetual capital and less dependence on realization-driven carry should hold up better. That creates a relative-value opportunity in the group, favoring firms with higher recurring fee mix and lower sensitivity to transaction activity. Over the next 1-2 quarters, the key catalyst is whether management frames this as a timing issue or a structural compression in fee margins and realization cadence.

The contrarian angle is that the market may be over-penalizing headline misses while underappreciating that ARES is still growing top line materially faster than public-market asset managers. If capital formation and deployment remain intact, a reset in expectations could set up a cleaner beat path later in the year. But absent a strong guide-up or evidence of improving estimate revisions, the path of least resistance is still lower because consensus is likely too high on both near-term EPS and revenue conversion.

Key Decisions for Investors

• Short ARES into the next earnings-call catalyst or post-call guidance update; best risk/reward is if management offers no clear acceleration in fee-related earnings or realizations, with downside likely to continue over the next 4-8 weeks.
• Pair trade: long BLK or KKR vs short ARES for 1-3 months, targeting relative outperformance by firms with stronger recurring fee durability and less reliance on volatile realization income.
• If holding ARES, buy downside protection via 1-2 quarter puts rather than selling outright; the name is vulnerable to another estimate-revision downdraft, but a call-driven squeeze can still happen if guidance improves.
• Avoid chasing the dip until consensus revisions stabilize; wait for at least one positive post-earnings estimate revision cycle before adding exposure.
• For opportunistic longs, consider a basket trade long the most recurring-fee alternative managers and short the more cyclical private-markets exposures; the relative trade should work if exit markets stay sluggish for another 1-2 quarters.